InsidersTradesSigma
Browse the detailed record of transactions filed by Schwalm Cynthia, Director. Insider active across 1 companies, notably G1 Therapeutics, Inc.. Aggregated, 2 filings have been published. The latest transaction was disclosed on 17 June 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Cynthia Schwalm is a Board Member at G1 Therapeutics, Inc. She plays a key role in the governance of the company, providing strategic advice and overseeing growth initiatives. Her expertise in the biopharmaceutical sector is valuable for the company's future direction.